493 related articles for article (PubMed ID: 33178630)
21. Divergent co-transcriptomes of different host cells infected with Toxoplasma gondii reveal cell type-specific host-parasite interactions.
Swierzy IJ; Händel U; Kaever A; Jarek M; Scharfe M; Schlüter D; Lüder CGK
Sci Rep; 2017 Aug; 7(1):7229. PubMed ID: 28775382
[TBL] [Abstract][Full Text] [Related]
22. Virulence factors of Toxoplasma gondii.
Dubremetz JF; Lebrun M
Microbes Infect; 2012 Dec; 14(15):1403-10. PubMed ID: 23006855
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of ATF6β-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18.
Yamamoto M; Takeda K
Virulence; 2012; 3(1):77-80. PubMed ID: 22286708
[TBL] [Abstract][Full Text] [Related]
24. The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading.
Kim EW; Nadipuram SM; Tetlow AL; Barshop WD; Liu PT; Wohlschlegel JA; Bradley PJ
mSphere; 2016; 1(2):. PubMed ID: 27303719
[TBL] [Abstract][Full Text] [Related]
25. Experimental approaches to understanding virulence in toxoplasmosis.
Sibley LD; Mordue D; Howe DK
Immunobiology; 1999 Dec; 201(2):210-24. PubMed ID: 10631570
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
[TBL] [Abstract][Full Text] [Related]
27. Secreted effectors in Toxoplasma gondii and related species: determinants of host range and pathogenesis?
English ED; Adomako-Ankomah Y; Boyle JP
Parasite Immunol; 2015 Mar; 37(3):127-40. PubMed ID: 25655311
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Control of IFN-γ Host Responses During Infection With
Nast R; Choepak T; Lüder CGK
Front Immunol; 2020; 11():581241. PubMed ID: 33072127
[TBL] [Abstract][Full Text] [Related]
29. TgROP18 targets IL20RB for host-defense-related-STAT3 activation during Toxoplasma gondii infection.
Kong L; Jiang D; He C; Xia J; Wei H; Zhou L; Peng H
Parasit Vectors; 2020 Aug; 13(1):400. PubMed ID: 32767999
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii and mucosal immunity.
Kasper L; Courret N; Darche S; Luangsay S; Mennechet F; Minns L; Rachinel N; Ronet C; Buzoni-Gatel D
Int J Parasitol; 2004 Mar; 34(3):401-9. PubMed ID: 15003499
[TBL] [Abstract][Full Text] [Related]
31. Functional Characterization of Dense Granule Proteins in
Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
[TBL] [Abstract][Full Text] [Related]
32. The role of host autophagy machinery in controlling
Besteiro S
Virulence; 2019 Dec; 10(1):438-447. PubMed ID: 30269643
[No Abstract] [Full Text] [Related]
33. TGF-β1 levels and intraocular tissue alterations in mice infected with a virulent type I RH Toxoplasma gondii strain.
Iqbal J; Al-Awadhi MA; Raghupathy RG
Exp Parasitol; 2016 Mar; 162():57-63. PubMed ID: 26773166
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis.
Lüder CG; Gross U
Curr Top Microbiol Immunol; 2005; 289():219-37. PubMed ID: 15791958
[TBL] [Abstract][Full Text] [Related]
35. Mucosal immunity in Toxoplasma gondii infection.
Schulthess J; Fourreau D; Darche S; Meresse B; Kasper L; Cerf-Bensussan N; Buzoni-Gatel D
Parasite; 2008 Sep; 15(3):389-95. PubMed ID: 18814712
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasmosis and Psychiatric and Neurological Disorders: A Step toward Understanding Parasite Pathogenesis.
Abo-Al-Ela HG
ACS Chem Neurosci; 2020 Aug; 11(16):2393-2406. PubMed ID: 31268676
[TBL] [Abstract][Full Text] [Related]
37. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
Behnke MS; Dubey JP; Sibley LD
Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
[TBL] [Abstract][Full Text] [Related]
38. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host.
Saeij JP; Boyle JP; Boothroyd JC
Trends Parasitol; 2005 Oct; 21(10):476-81. PubMed ID: 16098810
[TBL] [Abstract][Full Text] [Related]
39. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.
Welter A; Mineo JR; de Oliveira Silva DA; Lourenço EV; Vieira Ferro EA; Roque-Barreira MC; Maria da Silva N
Int J Exp Pathol; 2007 Oct; 88(5):325-35. PubMed ID: 17877534
[TBL] [Abstract][Full Text] [Related]
40. Deletion of mitogen-activated protein kinase 1 inhibits development and growth of Toxoplasma gondii.
Cao L; Wang Z; Wang S; Li J; Wang X; Wei F; Liu Q
Parasitol Res; 2016 Feb; 115(2):797-805. PubMed ID: 26526952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
